ReachRxResearch
Home
Research
Sign Up
  1. Home
  2. Research Hub
  3. Pain Phenotypes in Patients with Inflamm…

Pain Phenotypes in Patients with Inflammatory Myopathies: A Latent Class Analysis

Arthritis Care & Research·September 15
RheumatologyLimited evidenceFibromyalgiaIdiopathic Inflammatory MyopathyMyositisCross-Sectional Survey StudyAdult

Summary

View source

What was studied

An anonymous international electronic survey of 426 patients with self-reported idiopathic inflammatory myopathies (IIM) and myositis-related pain used latent class analysis (LCA) to identify distinct pain phenotypes, incorporating pain distribution, pattern, flare vs. current pain, and disease duration.

Key findings

LCA identified 4 pain phenotypes: class 1 (proximal limb-predominant, lowest persistent pain, earlier disease, lowest fibromyalgia rates); class 2 (diffuse axial and proximal limb pain, intermediate fibromyalgia burden); class 3 (diffuse axial and distal-leg pain, intermediate fibromyalgia burden); and class 4 (widespread axial and extremity pain, highest persistent pain and fibromyalgia rates).

Study limitations

Self-reported diagnosis and pain without clinical verification; anonymous survey design prevents confirmation of IIM subtype or disease activity; cross-sectional design limits causal inference about phenotype progression.

Clinical implications

Myositis-related pain is not uniform — clinicians should screen for fibromyalgia-like nociplastic patterns (especially widespread, persistent pain) in IIM patients, as these may require distinct management beyond standard immunosuppression.

Caveats

  • IIM diagnosis was self-reported and not clinically verified, which may introduce significant classification bias.
  • Latent class analysis is exploratory; the four-class solution reflects statistical fit and may not map directly to biological mechanisms without further validation.
  • Sex breakdown of the sample was not reported in the abstract; the 'mixed' sex tag is assumed based on the international survey design.

Related Questions

Explore related topics

How should fibromyalgia-like pain be managed in patients with inflammatory myopathies?What pain assessment tools are validated for use in idiopathic inflammatory myopathy?How does nociplastic pain differ from nociceptive pain in autoimmune muscle disease?

Publication Details

Year
2026
Journal
Arthritis Care & Research
Sample Size
n=426
Source
View article
Keep scrolling
More content below.
Up Next